|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Atara Biotherapeutics, Inc. (ATRA) |
|
|
$0.39 0.00 (0.00%) as of 4:30 Tue 6/18
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
108,674,000 |
Market
Cap: |
42.88(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2298 - $2.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 707 |
Guru Rank Value : 1.9 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
816,825 |
816,825 |
Total Buy Value |
$0 |
$0 |
$194,885 |
$194,885 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
4 |
4 |
Total Shares Sold |
211,204 |
267,396 |
419,842 |
591,605 |
Total Sell Value |
$130,313 |
$170,773 |
$340,560 |
$980,941 |
Total People Sold |
5 |
5 |
6 |
9 |
Total Sell Transactions |
5 |
10 |
23 |
41 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-07-20 |
4 |
AS |
$21.99 |
$105,552 |
I/I |
(4,800) |
320,311 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-07-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
330,957 |
0 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-07-08 |
4 |
AS |
$22.96 |
$110,208 |
I/I |
(4,800) |
325,111 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-07-07 |
4 |
AS |
$22.80 |
$109,440 |
I/I |
(4,800) |
329,911 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-06-24 |
4 |
AS |
$21.32 |
$102,336 |
I/I |
(4,800) |
334,711 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-06-23 |
4 |
AS |
$21.19 |
$101,712 |
I/I |
(4,800) |
339,511 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-06-08 |
4 |
AS |
$20.79 |
$99,792 |
I/I |
(4,800) |
344,311 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-06-07 |
4 |
AS |
$20.25 |
$146,580 |
I/I |
(7,200) |
349,111 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-05-26 |
4 |
AS |
$17.35 |
$62,460 |
I/I |
(3,600) |
356,311 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-05-25 |
4 |
AS |
$18.03 |
$64,908 |
I/I |
(3,600) |
359,911 |
|
- |
|
Gallagher Carol Giltner |
Director |
|
2016-05-18 |
4 |
AS |
$15.96 |
$18,897 |
D/D |
(1,184) |
95,462 |
|
- |
|
Soffer Gad |
Chief Operating Officer |
|
2016-05-17 |
4 |
AS |
$15.91 |
$86,344 |
D/D |
(5,427) |
136,844 |
|
- |
|
Gallagher Carol Giltner |
Director |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,366 |
96,646 |
|
- |
|
Mcgrath John |
Chief Financial Officer |
|
2016-05-16 |
4 |
AS |
$15.77 |
$85,079 |
D/D |
(5,395) |
88,822 |
|
- |
|
Mcgrath John |
Chief Financial Officer |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,503 |
94,217 |
|
- |
|
Haqq Christopher |
Chief Medical Officer |
|
2016-05-16 |
4 |
AS |
$15.57 |
$24,990 |
D/D |
(1,605) |
294,465 |
|
- |
|
Haqq Christopher |
Chief Medical Officer |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
830 |
296,070 |
|
- |
|
Soffer Gad |
Chief Operating Officer |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
142,271 |
|
- |
|
Fust Matthew K |
Director |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,602 |
13,888 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,907 |
223,228 |
|
- |
|
Clark Mitchall G. |
Chief R & QA Officer |
|
2016-05-16 |
4 |
AS |
$15.15 |
$62,918 |
D/D |
(4,153) |
83,759 |
|
- |
|
Clark Mitchall G. |
Chief R & QA Officer |
|
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,212 |
87,912 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-04-26 |
4 |
AS |
$20.15 |
$2,015 |
I/I |
(100) |
363,511 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-04-25 |
4 |
AS |
$20.12 |
$24,144 |
I/I |
(1,200) |
363,611 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2016-04-12 |
4 |
AS |
$20.20 |
$24,240 |
I/I |
(1,200) |
364,811 |
|
- |
|
736 Records found
|
|
Page 24 of 30 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|